menu search

Omega therapeutics to present new preclinical data on otx-2101 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics

CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pion...

October 4, 2023, 4:00 pm

Kura oncology announces three presentations at aacr-nci-eortc international conference on molecular targets and cancer therapeutics

– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapies, including TKIs, KRASG12C inhibitors and KRA...

October 4, 2023, 11:30 am

Foghorn therapeutics to present clinical and pre-clinical data from multiple programs across its diverse pipeline at aacr-nci-eortc international conference

CAMBRIDGE, Mass., Oct. 04, 2023 (GLOBE NEWSWIRE) -- Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company pioneering a ne...

October 4, 2023, 8:00 am

Karuna therapeutics to present data from the emergent program evaluating karxt in schizophrenia at the 36th european college of neuropsychopharmacology (ecnp) congress

BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), a biopharmaceutical company driven to discover, develop, and deliver transformative...

October 4, 2023, 6:30 am

Novartis ceo: company set to become a pure play, innovative medicine business after sandoz spin off

Vas Narasimhan, CEO at Novartis, discusses the company's 100% spin off of Sandoz, its generic and biosimilar m...

October 3, 2023, 11:26 am

Drugmakers sign on to negotiate medicare prices under protest

All the drugmakers that make the 10 prescription medicines subject to the first-ever price negotiations...

October 2, 2023, 1:02 pm

Clade therapeutics announces the acquisition of gadeta b.v.

Expands Clade’s pipeline and broadens its platform with:– proprietary gamma/delta (g/d) TCR universal targeting platform technology,– g/d TCR ca...

October 2, 2023, 12:30 pm

Aclaris therapeutics: the many lives of this biopharmaceutical developer

Aclaris Therapeutics is a developer of kinome-based medicines for immune-inflammatory and oncology indi...

September 28, 2023, 7:18 am

Crispr therapeutics to present at the society for immunotherapy of cancer (sitc) 38th annual meeting

ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating tr...

September 27, 2023, 9:01 am

Zoetis is an impressive healthcare compounder

Zoetis Inc., the world's largest provider of animal medicines, vaccines, and diagnostic products, is capitalizing on the growing trend of pet pamperin...

September 26, 2023, 5:56 pm

Verve to present interim data from the heart-1 phase 1b clinical trial of verve-101 in hefh patients at the american heart association’s scientific sessions 2023

Company to hold investor event in conjunction with data presentation on November 12, 2023 BOSTON, Sept. 26, 2023 (GLOBE NEWSWIRE) — Verve Therapeuti...

September 26, 2023, 10:30 am

2 monster stocks to buy without any hesitation

Johnson & Johnson and Intuitive Surgical are both leaders in their industries and long-time market beaters. Johnson & Johnson has a knack for developi...

September 26, 2023, 7:41 am

Nuvectis pharma announces updated date and time for the 2023 cantor global healthcare conference corporate presentation

Fort Lee, NJ, Sept. 25, 2023 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biophar...

September 25, 2023, 11:30 pm

Nuvectis pharma announces updated date and time for the 2023 cantor global healthcare conference corporate presentation

Fort Lee, NJ, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Nuvectis Pharma, Inc. (NASDAQ: NVCT) ("Nuvectis" or the "Company"), a clinical-stage biopharmaceutica...

September 25, 2023, 7:30 pm

Pfizer restarts production at tornado-hit north carolina plant, but drug supply will still be affected

Pfizer expects operations to fully resume by the end of the year, but it warned that supply of some medicines ...

September 25, 2023, 4:16 pm

Omega therapeutics to host conference call to discuss preliminary clinical data for otx-2002 from ongoing mychelangelo™ i trial on september 26

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Omega Therapeutics, Inc. (Nasdaq: OMGA) (“Omega”), a clinical-stage biotechnology company pio...

September 25, 2023, 4:00 pm

Revolution medicines: a big pipeline in need of big data

Revolution Medicines, Inc. has a diversified pipeline of drugs but is still searching for its flagship project, making it a high-risk investment. The ...

September 25, 2023, 3:24 pm

Wave life sciences to present at the chardan 7th annual genetic medicines conference

CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage RNA ...

September 25, 2023, 12:30 pm

Week in review: everest acquires novel autoimmune therapy in $132 million agreement

Shanghai Everest medicines acquired China/Asian rights to a novel therapy for autoimmune diseases from ...

September 24, 2023, 10:33 pm

Swiss government generics push could cut 250 million from health bill

Many drugs come in two forms: expensive branded drugs and cheaper generic copies. Switzerland’s Federal Council hopes a shift to cheaper generic and...

September 22, 2023, 4:14 pm


Search within

Pages Search Results: